| scholarly article | Q13442814 |
| P50 | author | Stephen L. Hauser | Q7609730 |
| Antje Bischof | Q85643745 | ||
| Ariele L Greenfield | Q102220100 | ||
| Erica L Eggers | Q114403604 | ||
| Akshaya Ramesh | Q114403622 | ||
| Natalie S Pierson | Q125289085 | ||
| Michael R Wilson | Q56434547 | ||
| P2093 | author name string | Hao Wu | |
| Martin S Weber | |||
| Bruce Ac Cree | |||
| Roland G Henry | |||
| H-Christian von Büdingen | |||
| Sarah Laurent | |||
| Ravi Dandekar | |||
| William Harkin | |||
| P2860 | cites work | Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis | Q22252943 |
| Vascular, glial, and lymphatic immune gateways of the central nervous system | Q28071461 | ||
| The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response | Q28541466 | ||
| Circos: an information aesthetic for comparative genomics | Q29547653 | ||
| Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. | Q34052870 | ||
| Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time | Q34073320 | ||
| Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. | Q34251673 | ||
| Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis | Q34538912 | ||
| IgBLAST: an immunoglobulin variable domain sequence analysis tool | Q34720205 | ||
| Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin | Q34960518 | ||
| MENINGEAL INFLAMMATION AND CORTICAL DEMYELINATION IN ACUTE MULTIPLE SCLEROSIS | Q58552252 | ||
| Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis | Q61230854 | ||
| A new primate model for multiple sclerosis in the common marmoset | Q73822837 | ||
| Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis | Q79992105 | ||
| IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences | Q84245408 | ||
| The Multiple Roles of B Cells in Multiple Sclerosis and Their Implications in Multiple Sclerosis Therapies | Q88376284 | ||
| Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions | Q35090021 | ||
| B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes | Q35298764 | ||
| Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation | Q35647840 | ||
| A germinal center-independent pathway generates unswitched memory B cells early in the primary response | Q35825984 | ||
| The Charcot Lecture | beating MS: a story of B cells, with twists and turns | Q36086475 | ||
| B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue. | Q36220292 | ||
| Cellular Dynamics of Memory B Cell Populations: IgM+ and IgG+ Memory B Cells Persist Indefinitely as Quiescent Cells | Q36260505 | ||
| Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis | Q36351504 | ||
| Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis | Q36639659 | ||
| Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching | Q37146773 | ||
| The relation between inflammation and neurodegeneration in multiple sclerosis brains. | Q37181308 | ||
| B cells as therapeutic targets in autoimmune neurological disorders | Q37278022 | ||
| Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. | Q37285430 | ||
| MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies | Q37397820 | ||
| Long-term evolution of multiple sclerosis disability in the treatment era. | Q37409279 | ||
| Eye on the B-ALL: B-cell receptor repertoires reveal persistence of numerous B-lymphoblastic leukemia subclones from diagnosis to relapse. | Q37500642 | ||
| Onset of secondary progressive MS after long-term rituximab therapy - a case report. | Q37572960 | ||
| In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses. | Q37652977 | ||
| Ectopic lymphoid-like structures in infection, cancer and autoimmunity | Q38221815 | ||
| Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study | Q38758444 | ||
| Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis | Q39119839 | ||
| Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis | Q40400256 | ||
| Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis | Q40400262 | ||
| B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome | Q41124267 | ||
| Oligoclonal "fingerprint" of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon | Q42583785 | ||
| Maintenance of B lymphocyte-related clones in the cerebrospinal fluid of multiple sclerosis patients | Q42613948 | ||
| B Cell Therapy for Multiple Sclerosis: Entering an Era. | Q46583404 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients. | Q47935420 | ||
| MiXCR: software for comprehensive adaptive immunity profiling. | Q48193977 | ||
| Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
| Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands". | Q48412765 | ||
| Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. | Q48427388 | ||
| Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis | Q48949365 | ||
| The role of brain barriers in fluid movement in the CNS: is there a 'glymphatic' system? | Q50048969 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state. | Q52016419 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| neuroscience | Q207011 | ||
| P577 | publication date | 2019-03-21 | |
| P1433 | published in | JCI insight | Q27727187 |
| P1476 | title | Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis | |
| P478 | volume | 4 |
Search more.